WHO Europe urges robust regulatory and ethical safeguards as AI’s role in European hospital care expands rapidly, highlighting urgent operational, legal, and risk management implications for leaders.

A Bangkok summit unites hospital leaders, researchers, and policymakers to launch a trans-Asian 'Health Silk Road' driving integration of AI, biotechnology, and traditional medicine for future-ready healthcare delivery.

The European Commission has approved Remsima™ IV liquid formulation, marking a major advance in hospital infusion therapy for inflammatory diseases.

Radiology Partners has acquired a healthcare artificial intelligence company for $80 million, aiming to accelerate clinical AI deployments across American radiology practices.

Lundbeck's new drug application for Vyepti® has been accepted in Japan, China, and South Korea, paving the way for expanded access to preventive migraine treatment across key Asian markets.

Laxxon Medical presents advanced pharmaceutical delivery systems and explores new partnerships at one of Europe's most significant healthcare industry events in London, 17-20 November 2025.

At a major summit in Bangkok, Asian healthcare leaders launched the 'Health Silk Road' initiative, focusing on fusing traditional medicine, AI, and biotechnology to set new integration standards for hospital management across the continent.

A major healthcare summit in Bangkok positions Asia at the forefront of global healthcare by championing the integration of traditional medicine, biotechnology, AI, and international cooperation, aiming for systemic innovation and collaboration.

Ping An Group inaugurates its first self-operated rehabilitation hospital in Shenzhen, marking a major advancement for integrated rehabilitation and digital health services in China.

Europe's top hospitals form new alliance to advance AI-driven prevention and advanced therapies across borders.